{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:06:08Z","timestamp":1787429168948,"version":"build-2736575974"},"reference-count":30,"publisher":"BMJ","issue":"23","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[2016,12,1]]},"DOI":"10.1136\/heartjnl-2016-309402","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T02:33:15Z","timestamp":1468377195000},"page":"1883-1889","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies"],"prefix":"10.1136","volume":"102","author":[{"given":"Kasper","family":"Adelborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-0865","authenticated-orcid":false,"given":"Erik Lerkevang","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Sundb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"key-10.1136\/heartjnl-2016-309402-1","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"key-10.1136\/heartjnl-2016-309402-2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"key-10.1136\/heartjnl-2016-309402-3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"key-10.1136\/heartjnl-2016-309402-4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S59156","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999\u20132012","volume":"6","author":"Schmidt","year":"2014","journal-title":"Clin Epidemiol"},{"key":"key-10.1136\/heartjnl-2016-309402-5","unstructured":"Danish Health Data Authority. Own calculations based on data from MEDSTAT. http:\/\/www.medstat.dk (accessed 20 Jan 2016)."},{"key":"key-10.1136\/heartjnl-2016-309402-6","article-title":"Data resource profile: the Danish online drug use statistics (MEDSTAT)","author":"Schmidt","journal-title":"Int J Epidemiol"},{"key":"key-10.1136\/heartjnl-2016-309402-7","unstructured":"Statistics Denmark. Statbank Denmark. http:\/\/www.statistikbanken.dk\/statbank5a\/default.asp?w=2021 (accessed 01 May 2016)."},{"key":"key-10.1136\/heartjnl-2016-309402-8","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"key-10.1136\/heartjnl-2016-309402-9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association science advisory and coordinating committee","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"key-10.1136\/heartjnl-2016-309402-10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. the medical research council's general practice research framework","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"key-10.1136\/heartjnl-2016-309402-11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"key-10.1136\/heartjnl-2016-309402-12","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"key-10.1136\/heartjnl-2016-309402-13","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"key-10.1136\/heartjnl-2016-309402-14","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"Sorensen","year":"2009","journal-title":"Lancet"},{"key":"key-10.1136\/heartjnl-2016-309402-15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"key-10.1136\/heartjnl-2016-309402-16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1517\/14656566.2015.1079619","article-title":"Antiplatelet therapy in acute coronary syndromes","volume":"16","author":"Grove","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.1136\/heartjnl-2016-309402-19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-21","unstructured":"Danish Medicines Agency. Historical prices of medicine. http:\/\/www.medicinpriser.dk\/ (accessed 21 Mar 2016)."},{"key":"key-10.1136\/heartjnl-2016-309402-22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"key-10.1136\/heartjnl-2016-309402-23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/heartjnl-2016-309402-24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1185\/03007995.2013.803462","article-title":"Venous thromboembolism management: where do novel anticoagulants fit?","volume":"29","author":"Spyropoulos","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"key-10.1136\/heartjnl-2016-309402-28","doi-asserted-by":"crossref","first-page":"IV13","DOI":"10.1161\/01.CIR.0000150640.98772.af","article-title":"Preventing venous thromboembolism in medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"key-10.1136\/heartjnl-2016-309402-29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.1136\/heartjnl-2016-309402-30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2016-309402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:37:55Z","timestamp":1601051875000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2016-309402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2016,11,11]]},"published-print":{"date-parts":[[2016,12,1]]}},"alternative-id":["10.1136\/heartjnl-2016-309402"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2016-309402","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}